Tag Archive for: Novartis

Roche, Herzog&De Meuron
M&A

Roche makes takeover bid for Poseida Therapeutics Inc

Genentech, the US arm of Swiss-based Roche AG, plans to acquire its long-time partner in allogeneic CAR-T blood cancer and gene therapies, Poseida Therapeutics Inc, for up to US$1.5bn.

Read more
© Niclas Jessen Studio/Bracco Imaging SpA
Financing

Blue Therapeutics gets financing to push radiotherapies

Radiopharmaceuticals specialist Blue Earth Therapeutics Ltd will use a U$76.5m Series A financing to finance Phase II development of its targeted prostate cancer radiopharmaceuticals Lutetium (177-Lu) rhPSMA-10.1 and Actinium (225-Ac) rhPSMA-10.1.

Read more